Artificial Cells and HepG2 Cells in 3D‐Bioprinted Arrangements

Abstract

Artificial cells are engineered units with cell‐like functions for different purposes including acting as supportive elements for mammalian cells. Artificial cells with minimal liver‐like function are made of alginate and equipped with metalloporphyrins that mimic the enzyme activity of a member of the cytochrome P450 family namely CYP1A2. The artificial cells are employed to enhance the dealkylation activity within 3D bioprinted structures composed of HepG2 cells and these artificial cells. This enhancement is monitored through the conversion of resorufin ethyl ether to resorufin. HepG2 cell aggregates are 3D bioprinted using an alginate/gelatin methacryloyl ink, resulting in successful proliferation of the HepG2 cells. The composite ink made of an alginate/gelatin liquid phase with increasing amount of artificial cells is characterized. The CYP1A2‐like activity of artificial cells is preserved over at least 35 days, where 6 nM resorufin was produced in 8 hours. Composite inks made of artificial cells and HepG2 cell aggregates in a liquid phase are used for 3D bioprinting. The HepG2 cells proliferate over 35 days, and the structure has boosted CYP1A2 activity. The integration of artificial cells and their living counter parts into larger 3D semi‐synthetic tissues is a step towards exploring bottom‐up synthetic biology in tissue engineering.This article is protected by copyright. All rights reserved